These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19534515)

  • 1. Quantum mechanics/molecular mechanics studies on the sulfoxidation of dimethyl sulfide by compound I and compound 0 of cytochrome P450: which is the better oxidant?
    Porro CS; Sutcliffe MJ; de Visser SP
    J Phys Chem A; 2009 Oct; 113(43):11635-42. PubMed ID: 19534515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can ferric-superoxide act as a potential oxidant in P450(cam)? QM/MM investigation of hydroxylation, epoxidation, and sulfoxidation.
    Lai W; Shaik S
    J Am Chem Soc; 2011 Apr; 133(14):5444-52. PubMed ID: 21413763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the axial ligand on substrate sulfoxidation mediated by iron(IV)-oxo porphyrin cation radical oxidants.
    Kumar D; Sastry GN; de Visser SP
    Chemistry; 2011 May; 17(22):6196-205. PubMed ID: 21469227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantum Mechanics/Molecular Mechanics Studies on the Relative Reactivities of Compound I and II in Cytochrome P450 Enzymes.
    Postils V; Saint-André M; Timmins A; Li XX; Wang Y; Luis JM; Solà M; de Visser SP
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic studies of reactions of iron(IV)-oxo porphyrin radical cations with organic reductants.
    Pan Z; Zhang R; Newcomb M
    J Inorg Biochem; 2006 Apr; 100(4):524-32. PubMed ID: 16500709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multireference ab initio quantum mechanics/molecular mechanics study on intermediates in the catalytic cycle of cytochrome P450(cam).
    Altun A; Kumar D; Neese F; Thiel W
    J Phys Chem A; 2008 Dec; 112(50):12904-10. PubMed ID: 18543897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One oxidant, many pathways: a theoretical perspective of monooxygenation mechanisms by cytochrome P450 enzymes.
    Shaik S; de Visser SP; Kumar D
    J Biol Inorg Chem; 2004 Sep; 9(6):661-8. PubMed ID: 15365903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview on theoretical studies discriminating the two-oxidant versus two-state-reactivity models for substrate monoxygenation by cytochrome P450 enzymes.
    de Visser SP; Porro CS; Quesne MG; Sainna MA; Munro AW
    Curr Top Med Chem; 2013; 13(18):2218-32. PubMed ID: 24047138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What factors influence the rate constant of substrate epoxidation by compound I of cytochrome P450 and analogous iron(IV)-oxo oxidants?
    Kumar D; Karamzadeh B; Sastry GN; de Visser SP
    J Am Chem Soc; 2010 Jun; 132(22):7656-67. PubMed ID: 20481499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the identity and reactivity patterns of the "second oxidant" of the T252A mutant of cytochrome P450cam in the oxidation of 5-methylenenylcamphor.
    Hirao H; Kumar D; Shaik S
    J Inorg Biochem; 2006 Dec; 100(12):2054-68. PubMed ID: 17084458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundamental differences of substrate hydroxylation by high-valent iron(IV)-oxo models of cytochrome P450.
    Tahsini L; Bagherzadeh M; Nam W; de Visser SP
    Inorg Chem; 2009 Jul; 48(14):6661-9. PubMed ID: 19469505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The elusive oxidant species of cytochrome P450 enzymes: characterization by combined quantum mechanical/molecular mechanical (QM/MM) calculations.
    Schöneboom JC; Lin H; Reuter N; Thiel W; Cohen S; Ogliaro F; Shaik S
    J Am Chem Soc; 2002 Jul; 124(27):8142-51. PubMed ID: 12095360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the bound substrate in nitric oxide synthase protonated or neutral and what is the active oxidant that performs substrate hydroxylation?
    de Visser SP; Tan LS
    J Am Chem Soc; 2008 Oct; 130(39):12961-74. PubMed ID: 18774806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can a single oxidant with two spin states masquerade as two different oxidants? A study of the sulfoxidation mechanism by cytochrome p450.
    Sharma PK; De Visser SP; Shaik S
    J Am Chem Soc; 2003 Jul; 125(29):8698-9. PubMed ID: 12862444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound I reactivity defines alkene oxidation selectivity in cytochrome P450cam.
    Lonsdale R; Harvey JN; Mulholland AJ
    J Phys Chem B; 2010 Jan; 114(2):1156-62. PubMed ID: 20014756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axial ligand and spin-state influence on the formation and reactivity of hydroperoxo-iron(III) porphyrin complexes.
    Franke A; Fertinger C; van Eldik R
    Chemistry; 2012 May; 18(22):6935-49. PubMed ID: 22532376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity Patterns of (Protonated) Compound II and Compound I of Cytochrome P450: Which is the Better Oxidant?
    Li XX; Postils V; Sun W; Faponle AS; Solà M; Wang Y; Nam W; de Visser SP
    Chemistry; 2017 May; 23(26):6406-6418. PubMed ID: 28295741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward identification of the compound I reactive intermediate in cytochrome P450 chemistry: a QM/MM study of its EPR and Mössbauer parameters.
    Schöneboom JC; Neese F; Thiel W
    J Am Chem Soc; 2005 Apr; 127(16):5840-53. PubMed ID: 15839682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity patterns of cytochrome P450 enzymes: multifunctionality of the active species, and the two states-two oxidants conundrum.
    Shaik S; Hirao H; Kumar D
    Nat Prod Rep; 2007 Jun; 24(3):533-52. PubMed ID: 17534529
    [No Abstract]   [Full Text] [Related]  

  • 20. Freeze-quenched iron-oxo intermediates in cytochromes P450.
    Jung C; Schünemann V; Lendzian F
    Biochem Biophys Res Commun; 2005 Dec; 338(1):355-64. PubMed ID: 16143295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.